Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHB2350500	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs	Supplementary Application	2023-06-16		Defengyaoye			view
CYHS2402858	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs(3)	Generic Drug	2024-08-31					view
CXL20022840	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs(4)	New Drug Application	2002-11-13	上海医药工业研究院	Shanghai Institute of Pharmaceutical Industry	Certificate Issued	2003-09-27	view
CYHB1707683	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs	Supplementary Application	2018-04-20	四川德峰药业有限公司	Defengyaoye	Certificate Issued	2019-04-24	view
CXL20021199	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs(2)	New Drug Application	2002-06-10	杭州民生药业集团有限公司	Hangzhou Minsheng Pharmaceutical Co Ltd	Certificate Issued	2003-05-09	view
CXHS0600461	富马酸依美斯汀缓释胶囊	emedastine difumarate	Capsules, extended release	Chemical Drugs(3.1)	New Drug Application	2006-04-30	杭州民生药业集团有限公司	Hangzhou Minsheng Pharmaceutical Co Ltd	Certificate Issued	2008-11-18	view